Early serum miR-1297 is an indicator of poor neurological outcome in patients with aSAH.

CONCLUSION: Serum was an independent predictive factor of poor outcome at 1-year following aSAH. This result supports the use of miR-1297 in aSAH to aid determination of prognosis.
PMID: 30355655 [PubMed - as supplied by publisher]

Source: Bioscience Reports - October 24, 2018 Category: Biomedical Science Authors: Sheng B, Lai NS, Yao Y, Dong J, Li ZB, Zhao XT, Liu JQ, Li XQ, Fang XG Tags: Biosci Rep Source Type: research